16,99 €
inkl. MwSt.

Versandfertig in 6-10 Tagen
  • Broschiertes Buch

Non-alcoholic Fatty Liver disease is the one of most common liver disease in the world, which is defined as the accumulation of fat 5% of liver weight. Presentation of the disease ranges from Simple Steatosis to Non-alcoholic Steatohepatitis, which is a progressive form that may lead to fibrosis, cirrhosis and ultimately hepatocellular carcinoma. Nonalcoholic Fatty Liver Disease is not a single disease, diagnosed by non-invasive biomarkers, imaging techniques and liver biopsy; non-invasive serum markers have been used in the assessment of Non-alcoholic Steatohepatitis, ranging from hepatocyte…mehr

Produktbeschreibung
Non-alcoholic Fatty Liver disease is the one of most common liver disease in the world, which is defined as the accumulation of fat 5% of liver weight. Presentation of the disease ranges from Simple Steatosis to Non-alcoholic Steatohepatitis, which is a progressive form that may lead to fibrosis, cirrhosis and ultimately hepatocellular carcinoma. Nonalcoholic Fatty Liver Disease is not a single disease, diagnosed by non-invasive biomarkers, imaging techniques and liver biopsy; non-invasive serum markers have been used in the assessment of Non-alcoholic Steatohepatitis, ranging from hepatocyte apoptosis by-product cytokeratin-18 fragments, liver biochemical profile serum such as alanine aminotransferase, aspartate aminotransferase, and nonspecific markers of systemic inflammation, such as interleukin-6.
Autorenporträt
Dr. Shahad A.Qassem Alkenani I worked for a whole year at the Cardiology Center / Iraq / Maysan I now work as a teacher in the pharmacy department / Al-Manara College of Medical Sciences / Iraq / Maysan I now work as a teacher at the Medical Technical Institute / Maysan / Iraq